Microarray data consists of mRNA expression levels of thousands of genes under certain conditions. A difference in the expression level of a gene at two different conditions/phenotypes, such as cancerous versus non-cancerous, one subtype of cancer versus another, before versus after a drug treatment, is indicative of the relevance of that gene to the difference of the high-level phenotype. Each gene can be ranked by its ability to distinguish the two conditions. We study how the single-gene classification ability decreases with its rank (a Zipf's plot). Power-law function in the Zipf's plot is observed for the four microarray datasets obtained from various cancer studies. This power-law behavior in the Zipf's plot is reminiscent of similar power-law curves in other natural and social phenomena (Zipf's law).
Introduction 2 Measure of importance of genes in cancer classification: likelihood
The measurement we use for the importance of genes in cancer classification is the maximized likelihood, which is proportional to the probability of observing the data when a model is given, and when the parameters in the model are adjusted to give the maximum value. Mathematically, likelihood L is [Edwards, 1972] :
where D is all data points in a data set, M is a model, θ represents all parameters in the model, and c is a proportional constant (often set to be 1). The maximized likelihood iŝ
where theˆrepresents a maximization/estimation procedure. The microarray data sets have the form of {x 1i , x 2i , · · · , x pi , y i } (i = 1, 2, · · · N ). Each sample point i (one microarray experiment, one tissue sample) contains measurements of (logarithm of ) mRNA expression level of p genes (p is typical of the order of thousands), and y is a categorical label indicating a condition (e.g. cancerous or normal). The raw data in a microarray experiment could be more complicated: one has to consider background noise, normalization, and controls. These considerations depend on the type of chips: Stanford/cDNA array with two fluorescence dyes [Schena, et al., 1995; Shalon et al., 1996] or Affymetrix/oligonucleotide arrays with only one image intensity to measure but multiple oligonucleotide probes [Fodor, et al., 1991] . In this paper, only the filtered/processed data are used and the subtle issue of scaling/normalization of the raw data is not discussed.
The model M is a classification model (classifier, predictor, discriminator, supervised learning machine), that classifies the label y by the gene expression level {x j } (logarithm of an image intensity from the DNA chip). We use a particularly simple classifier, the single-gene logistic regression:
P (y i = 1|x ji ) = 1 1 + e −aj −bj xji . j = 1, 2, · · · p, and i = 1, 2, · · · N.
In other words, the probability of a sample being in one class is a "sigmoid" or "logistic" function of the (log) expression level. If the coefficient b is positive, larger expression levels lead to higher probabilities of being the y = 1 label; if b < 0, larger expression level corresponds to the y = 0 label.
The likelihood of the whole data set is the product of these model-based probabilities (for a given gene):
where I is the indicator function (1 or 0 depending on whether the condition is true or not). Eq. (4) is maximized by adjusting the parameters in the model. The maximized likelihoodL can then be used to rank all genes: the larger theL, the higher the ranking. The binomial (two-class) logistic regression Eq.(3) has been applied to two microarray data sets. The first is colon cancer data from Princeton University [Alon, et al., 1999] . The expression levels of 2000 genes were available for 62 tissue samples: 40 cancerous and 22 normal. The second data set is leukemia data from Whitehead Institute/MIT [Golub, et al., 1999] . Expression levels of 7129 genes were measured on 72 leukemia samples: 47 obtained from tissues of one subtype of leukemia, acute lymphoblastic leukemia (ALL), and 25 from tissues of another subtype of leukemia, acute myeloid leukemia (AML). Although the number of labels is 2 for both datasets, we distinguish cancerous from normal tissues in the first data set, whereas distinguish one cancer subtype from another in the second data set.
For the colon cancer data, the single-gene maximized likelihood Eq.(4) for each gene was calculated and ranked. The likelihood-rank plot (Zipf's plot) is shown in Fig.1 in log-log scale. The power-law behavior of the curve is clearly visible. Fitting the first 600 genes using a generalized form of Zipf's law:
leads to exponent α ≈ 2.18, whereas the fitting of the top 1000 genes leads to α ≈ 2.10. The genes from roughly rank 1000 to 2000 do not seem to follow the same power-law decay of the likelihood. As will be discussed more later in this paper, the exponent α is not an intrinsic quantity for our likelihood-rank plots.
The reason is that the likelihood is a product of probabilities of N sample points L r ∝ (p 1 p 2 · · · p N ) r ∼p N r ; if the per-sample averaged likelihoodp r of rank-r gene does not change with the sample size N , the exponent α is then a function of N : α ∼ −N log(p r )/log(r). Fig.2 shows the Zipf's plot of the second data set. Among the 72 samples, 38 are from bone marrow tissues, and were separated as a training set in [Golub, et al., 1999] . These 38 samples were considered to be more homogeneous, while the rest of the samples were from various sources or other tissue types such as peripheral blood [Golub, et al., 1999] , and may not be homogeneous. From Fig.2 , the Zipf's plot obtained from the training set seems to follow a generalized form of Zipf's law with a fitting exponent of α ≈ 2.56 from the top 900 genes. The Zipf's plot of all sample points seems to deviate from a power-law trend around rank 100-200. As mentioned earlier, the exponent α from a bigger data set is indeed larger than the exponent from a small data set.
When the top genes are examined, it was found that the top-ranking genes for the training set [Li & Yang, 2001] and those for the overall set [Li, et al., 2001] may not be identical. For example, the top performing gene for the 38-sample training set is No.4847, zyxin, a gene encoding the LIM domain protein used in cell adhesion in fibroblasts [Golub, et al., 1999] . On the other hand, the best performing gene for the 72-sample combined set is No. 1834, CD33 antigene which encodes cell surface proteins commonly found in AML leukemia cells (see, e.g., [Lauria, et al., 1994] ). The zyxin becomes the rank-4 gene for the combined dataset. This difference reflects a certain degree of inhomogeneity between samples in the training set and those in the remaining set (testing or validation set). Note from Fig.1 that for the training set, genes from rank 3 to 9 exhibits similar likelihood, and form a flat step on the Zipf's plot. Such steps Li 5 are a dominant feature in the Zipf's plot of the frequency of word occurrence in randomly generated texts [Li, 1992] .
Classification of multiple cancer classes
The logistic regression Eq.(3) for a two-class data set can be generalized to multiple classes: multinomial logistic regression [Agresti, 1996] :
where the label y can be in one of the C classes, and there are two parameters for each class (though only C − 1 class probabilities are independent). A gene is important (higher maximized likelihood) if it is more able to distinguish all C classes simultaneously.
For this multiple-class analysis, we use the microarray data for lymphoma (Stanford University and National Cancer Institute [Alizadeh, et al., 2000] ). There are a total 96 tissue samples, with 66 cancerous and 30 normal. Within the cancer samples, there are 46 diffuse large B-cell lymphoma (DLBCL), 9 follicular lymphoma (FL), 11 chronic lymphocyte leukemia (CLL). These 3 cancer subtypes plus the normal are the 4 classes to be distinguished. In [Alizadeh, et al., 2000] , it is also recommended that two new subclasses of DLBCL can be defined based on the microarray data. These are the germinal centre B-like DLBCL (GC-DLBCL) and the activated B-like DLBCL (A-DLBCL). The GC-DLBCL, A-DLBCL subclasses plus the normal can be the 3 classes to be distinguished. 
Cancer treatment effect
Another interesting situation is provided by the data set from Stanford University and the Norwegian Radium Hospital [Perou, et al., 2000] . Part of the data is the expression level of 8102 genes measured before and after a 16-week course of doxorubicin chemotherapy [Perou, et al., 2000] on 20 patients. Naively, one may consider these 40 microarray experiments as an example of binary logistic regression. However, logistic regression in Eq.(3) does not apply because it requires samples to be independent of each other, whereas microarray experiments done on the same patient are clearly not independent. This situation can be handled by the logistic regression of paired case-controls (case is a sample with label 1, and control is a sample with label 0) [Breslow & Day, 1980] :
Note that the probability is no longer that for observing y -when a case sample and a control sample are paired, their y value is fixed at 1 and 0 -but that of observing the difference of x's. Also note that the first parameter a is now zero. Fig.4 shows the Zipf's plot for genes in the breast cancer microarray data. The top three genes were able to perfectly identify the chemotherapy effect -the expression level is always higher (or lower) before the treatment than after in all 20 samples. The likelihood of a perfect fit is equal to 1. Unlike the previous three plots, the likelihood of genes in Fig.4 does not follow a power-law function, or even a smooth function.
There seems to be a gap from the ranking of 19 to the ranking of 20-25. Fitting the two segments (from 4 to 19, and from 25 to 500) by power-law functions leads to different exponents (2.51 versus 1.77).
Plots like Fig.4 can be good news for a microarray data analysis, because there seems to be a separation between "relevant" and "irrelevant" genes. Irrelevant genes are not important for distinguishing samples before and after chemotherapy, and may be discarded for further analysis. Of course, this is only a rough description of the gene set. A more systematic approach can be based on the framework of model selection (see, e.g., [Burnham & Anderson, 1998 ]) or model averaging (see, e.g., [Geisser, 1993] ). With model selection, the expression level of different genes can be combined, and adding one gene increases the number of parameters in the model by 1. The appropriate number of genes to be included in a classification is the model with the best "model selection criterion" such as Akaike information criterion [Burnham & Anderson, 1998 ] or Bayesian information criterion [Raftery, 1995] , with a best balance between a larger likelihood value and fewer numbers of parameters [Li & Yang, 2001 , Li, et al., 2001 . With model averaging, there is in principle no limitation on the number of genes to be included, but irrelevant genes have smaller weights in an averaged classifier [Golub, et al., 1999 , Li & Yang, 2001 . This makes the effective number of genes used much smaller than the apparent number.
Scaling exponent
As mentioned earlier, the exponent of the inverse power-law fitting function for Zipf's plot (Figs. 1-4) depends on the sample size. The reason for this is that the measurement for the importance of a gene, the sample classification likelihood, is a function of the sample size. Here we ask the question whether one can define a normalized exponent. SinceL r ∼ 1/r α , we can obviously draw Zipf's plot for the per-sample likelihood:p r =L 1/N r ∼ 1/r (α/N ) . There is another consideration for classification of more than two labels: it is unfair to compare per-sample classification likelihoods when the number of classes differs. Just by random guess, the probability of classifying the label correctly for a binary-class case is 0.5, whereas that for classifying C labels is 1/C. We can normalize the per-sample likelihoodp r by the random-guess probability:l r =p r /(1/C) ∼ C/r (α/N ) with the same scaling exponent. Fig.5 shows the Zipf's plot of normalized per-sample likelihoodl r for all data sets analyzed so far. These curves can be compared in two ways. First, the performance of the top-ranking genes can be compared by theirl r 's. It is clear from Fig.5 that for the leukemia data, the performance obtained from the training set is better than that obtained from the whole set, indicating a possible heterogeneity in the data set.
The performance of the top genes for the breast cancer data set is better (in terms of classification) than that for the leukemia data set, which in turn is better than that for the colon cancer data set.
It is usually difficult to compare performance between a two-label classification and a multiple-label classification, because it depends on the base-line expectation. Two base-line expectations (called null models) were defined in [Li & Yang, 2001 , Li, et al., 2001 : one is to randomly guess all classes with equal probability, and another is to guess the class by the proportion of samples with this class in the data set.
In Fig.5 , the first base-line expectation is used as the normalization factor. The performance of the 4-label classification relative to this base-line expectation for the lymphoma data is considered to be better than that of the 3-label classification, partly due to its low expectation.
Different data sets in Fig.5 can also be compared by the rate of falling of likelihood. The fall-off rate, as measured by the scaling exponent α, ranges from 3 to 9 per 100 samples (i.e., α/N ≈ 0.03 − 0.09).
It is interesting that scaling exponents obtained from the leukemia data (both the whole data set and the training set) and from the lymphoma data (two DLBCL subtypes plus normal) are almost identical (around 65 -67 per 100 samples). The breast cancer data is different from other data sets for falling faster in the likelihood-rank plot.
Discussion
Results from Figs. 1-4 established that when microarray data is used to classify cancer tissues, the classification likelihood of individual genes follows a generalized form of Zipf's law. The reason that these power-law functions in the Zipf's plot do not have a scaling exponent equal to 1 is partly because exponent α in Eq.(5) depends on the sample size N . Besides the issue of the exponent value, the overall power-law trend is excellent: a perfect power-law function for all points in Fig.3 (3-label classification, in 3.5 decades), a partial power-law fitting in a range of 2.5 decades (Fig.1 ), 3 decades (Fig.2) , and 2 decades (Fig.3, 4 -label classification), respectively. The only poor fitting by a power-law function is Fig.4 .
The Zipf's plot is flattern out for low-ranking genes in Figs. 1 and 2 , while it drops off in Fig.3 (4-label classification). Which functional form is more generic for low-ranking genes is not clear, perhaps our results are sample-size sensitive.
Our Zipf's plot can be compared to those obtained from biomolecular sequences. In [Gamow & Ycas, 1955] , a Zipf's plot for 20 amino acids usage in protein sequences was presented (in linear-linear scale).
Redrawing their data in log-log scale does not show any power-law behavior (result not shown). Recently, it was claimed that oligonucleotide frequencies in DNA sequences follow Zipf's law [Mantegna, et al., 1994] . This paper drew criticism on its strong claim concerning the connection between Zipf's law and human language [Martindale & Konopka, 1995; Israeloff, et al., 1996 , Bonhoeffer, et al., 1996a ,1996b , Voss, 1996 :
one of the best counter-examples is Zipf's law in money-typing texts [Li, 1992] . Also, the paper did not show convincingly that the Zipf's plot for oligonucleotide usage was better fitted by a power-law function [Martindale & Konopka, 1996] : the deviation from the power-law fitting function can be gradual and systematic, an indication that the power-law function is not the best choice of fitting function. Finally, the scaling exponent in the power-law fitting function in [Mantegna, et al., 1994 ] is much smaller than 1 [Li, 1996] . In comparison, our Zipf's plots in Figs 1-5 are a much better example of a generalized form of Zipf's law than those in [Gamow & Ycas, 1955] and [Mantegna, et al., 1994] .
One may wonder whether the power-law behavior in Figs 1-5 can be derived by a simple random model.
In [Gamow & Ycas, 1955] , the Zipf's plot of the frequency of amino acids usage was compared to a "random partition of a unit length" model. Suppose a unit interval is randomly partitioned into p segments (e.g. p = 20 for 20 amino acids). These segments are ranked by their size
If this random partition is repeated, the mean value of the ranked size can be shown to be [Gamow & Ycas, 1955] :
Drawing < L (r) > from Eq.(8) versus rank r shows that it is a straight line in linear(y)-log(x) plot, and not a straight line in either log-log or log(y)-linear(x) plots (results not shown). Actually this analytic result may not be applicable to our case, because we keep track of the performance of a given gene on all samples, whereas in Eq.(8) the longest interval (or any given ranking interval) is averaged over all random simulation. In any case, the power-law behavior in Fig.1-5 does not seem to be explainable by a simple random model.
We may ask whether Zipf's plot has any practical application for microarray data analysis. In information retrieval [van Rijsbergen, 1975 , Salton, 1988 and library/documentation science [Egghe & Rousseau, 1990 ], Zipf's law is an important foundation that many applications are based upon. It is one of the "bibliometric laws" [White & McCain, 1989] concerning regularities in bibliographies, lists of authors, citation lists, etc. For the purpose of finding relevant, content-bearing words ("keywords"), common (highest-ranking) and rare (lowest-ranking) words should be avoided [Luhn, 1957 [Luhn, ,1958 ].
Do we have a similar situation where the highest-ranking genes may not be interesting for cancer classification? (Lowest-ranking genes are obviously not interesting.) Our ranking system is not really the same as for word usage, since a discrimination or classification ability has already been included in our definition, whereas it is not included in the word usage example. In this sense, our top ranking genes are in fact most efficient for the purpose of cancer classification. On the other hand, if one is more interested in subtle gene effects, not in the known main/dominant effect, it is perhaps useful to remove the well-known genes from the list and examine other genes in a future study. This idea was not tried in our previous analysis [Li & Yang, 2001 , Li, et al., 2001 ].
In conclusion, a generalized form of Zipf's law was observed in microarray data for the likelihood on cancer classification using single-gene logistic regression. We suspect that this power-law behavior is generic rather than an exception. A rank-likelihood plot (Zipf's plot) can be a useful quantitative tool for discriminant microarray data analysis.
• 
